Clinical Trials Browser

Phase 4 × Breast Neoplasms × Silymarin × Clear all

NCT04434404 2020-06-16

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Phase 4 Completed

Breast Neoplasms, Cardiotoxicity